
doi: 10.1007/bf02723715
pmid: 12450301
Juvenile idiopathic arthritis (JIA) is a relatively uncommon disorder in childhood. Expertise however should be the corner stone of care of children with JIA, as early appropriate treatment is mandatory to ensure best possible short and long-term outcome for children with JIA. Therefore comprehensive treatment centers (with multi disciplinary teams) should be based in tertiary level academic centers. This article deals with both specific and generic issues encountered in managing children with JIA.
Antirheumatic Agents, Arthritis, Immunoglobulin G, Humans, Osteoporosis, Child, Prognosis, Arthritis, Juvenile, Receptors, Tumor Necrosis Factor, Etanercept
Antirheumatic Agents, Arthritis, Immunoglobulin G, Humans, Osteoporosis, Child, Prognosis, Arthritis, Juvenile, Receptors, Tumor Necrosis Factor, Etanercept
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
